Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avenue Therapeutics, Inc.

0.5501
-0.0299-5.16%
Volume:3.43K
Turnover:1.89K
Market Cap:1.75M
PE:-0.81
High:0.5541
Open:0.5501
Low:0.5501
Close:0.5800
52wk High:3.54
52wk Low:0.1653
Shares:3.18M
Float Shares:2.83M
Volume Ratio:3.01
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6806
EPS(LYR):-8.9962
ROE:-185.46%
ROA:-86.89%
PB:0.43
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
Avenue Therapeutics, Inc.
Exchange:
PINK
Establishment Date:
2015
Employees:
2
Office Location:
1111 Kane Concourse,Suite 301,Bay Harbor Islands,Florida,United States
Zip Code:
33154
Fax:
- -
Introduction:
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.